Live News Categoriesmarket

TELO.V (TELO.V) News

Follow TELO.V (TELO.V) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol TELO.V Asset market Sector Markets 90 days 1 Updated Sep 29, 2026, 07:35 AM UTC Open live news feed

M Telo Genomics: TELO-MRD detects circulating malignant plasma cells in all clonoSEQ-positive myeloma cases reviewed The company says its blood-based TELO-MRD test detected circulating malignant plasma cells in all bone-marrow NGS MRD-positive cases reviewed, and in some cases deemed MRD-negative or non-evaluable by the NGS method; TEL EQUITY | Sep 29, 2026, 07:35 AM UTC